Unexpected encounter of the parasitic kind. by Matthews, H & Noulin, F
W J S C World Journal ofStem Cells
Submit a Manuscript: https://www.f6publishing.com World J Stem Cells  2019 November 26; 11(11): 904-919
DOI: 10.4252/wjsc.v11.i11.904 ISSN 1948-0210 (online)
REVIEW
Unexpected encounter of the parasitic kind
Holly Matthews, Florian Noulin
ORCID number: Holly Matthews
(0000-0002-3890-9098); Florian
Noulin (0000-0001-7430-8073).
Author contributions: Matthews H
and Noulin F performed the
literature search, and wrote and
edited the review.
Conflict-of-interest statement: The
authors declare no conflicts of
interest for this article.
Open-Access: This article is an
open-access article that was
selected by an in-house editor and
fully peer-reviewed by external
reviewers. It is distributed in
accordance with the Creative
Commons Attribution Non
Commercial (CC BY-NC 4.0)
license, which permits others to
distribute, remix, adapt, build
upon this work non-commercially,
and license their derivative works
on different terms, provided the
original work is properly cited and
the use is non-commercial. See:
http://creativecommons.org/licen
ses/by-nc/4.0/
Manuscript source: Invited
manuscript
Received: March 22, 2019
Peer-review started: March 22, 2019
First decision: August 1, 2019
Revised: August 10, 2019
Accepted: September 13, 2019
Article in press: September 13, 2019
Published  online:  November  26,
2019
P-Reviewer: Liu L
S-Editor: Zhang L
L-Editor: Filipodia
E-Editor: Xing YX
Holly Matthews, Florian Noulin, Centre for Applied Entomology and Parasitology, School of
Life Sciences, Keele University, Keele ST5 5BG, United Kingdom
Corresponding author: Florian Noulin, PhD, Research Associate, Centre for Applied
Entomology and Parasitology, School of Life Sciences, Keele University, Keele ST5 5BG,
United Kingdom. f.noulin@keele.ac.uk
Telephone: +44-17-82733026
Fax: +44-17-82733516
Abstract
Both parasitology and stem cell research are important disciplines in their own
right. Parasites are a real threat to human health causing a broad spectrum of
diseases and significant annual rates morbidity and mortality globally. Stem cell
research, on the other hand, focuses on the potential for regenerative medicine for
a range of diseases including cancer and regenerative therapies. Though these
two topics might appear distant, there are some “unexpected encounters”. In this
review, we summarise the various links between parasites and stem cells. First,
we discuss how parasites’ own stem cells represent interesting models of
regeneration that can be translated to human stem cell regeneration. Second, we
explore the interactions between parasites and host stem cells during the course
of infection. Third, we investigate from a clinical perspective, how stem cell
regeneration can be exploited to help circumvent the damage induced by
parasitic infection and its potential to serve as treatment options for parasitic
diseases in the future. Finally, we discuss the importance of screening for
pathogens during organ transplantation by presenting some clinical cases of
parasitic infection following stem cell therapy.
Key words: Stem cells; Parasites; Transplantation; Therapeutic; Host pathogen
interactions
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: The aim of this review was to bring together two important research disciplines:
parasitology and stem cell biology. Parasites are the caustic agents of numerous diseases
that have a huge impact on human health. The regeneration properties of stem cells are
remarkable and the exploitation of such biology for clinical applications is an exciting
area of research that may provide future treatment options for a wide range of human
diseases. These apparently independent fields of research have multiple areas of overlap
which we cover highlighting that these interactions, particularly from a clinical
perspective, should be more seriously considered and studied.
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INTRODUCTION
Stem cells are defined by their self-renewal properties, and their ability to differentiate
into adult cells[1]. They can be classified into two groups according to their biological
properties: Pluripotent and multipotent stem cells. Pluripotent stem cells are able to
differentiate into any cell type, and are found in the blastocyst, and early embryonic
developmental stage[2]. Pluripotent stem cells give rise to three germ layers (endo-
derm, mesoderm and ectoderm) that ultimately produce different organs: cardiac,
skeletal muscle or red blood cells for the mesoderm, pancreatic or lung cells for the
endoderm, and neuron or skin cells for the ectoderm (Figure 1). Multipotent stem cells
are more limited with regards to their differentiating capabilities. While they can
differentiate into multiple cell types, they are already polarised down a specific route
and can be found in most adult tissues where they replace aged or damaged cells
throughout the lifespan of the multicellular organism[3].
Parasites are organisms that survive by taking nutrients from another organism:
their host[4]. They represent more than 50% of all animal species[5] and can be broadly
divided into three groups: Protozoa, helminths, and ectoparasites (Figure 2). The
diseases they cause inflict huge health and socio-economic burden on low income
countries[6]. Indeed, parasitic infections were considered responsible for 7.2% of deaths
globally in 2016[7].
The relationship between parasites and stem cells is becoming increasingly studied
(Figure 3). The purpose of this review is to further examine the relationship between
stem cells and parasites, specifically looking at parasitic stem cells, how the parasites
influence the host’s stem cells, and how these interactions may be exploited clinically.
PARASITIC STEM CELLS
Although unicellular protozoan parasites do not have stem cells, the stems cells of
other multi-cellular parasites such as helminths have been studied. Interestingly, one
of  the  earliest  references  to  the  term “stem cell”  was  in  relation to  the  parasitic
helminth  Ascaris  megalocephala  in  the  late  19th  century[8].  Thus,  it  is  perhaps
unsurprising that some parasite’s stem cells have been used to better understand the
regeneration system.
Echinococcus
The tapeworm Echinococcus is one such parasite. This organism presents primarily as
a zoonosis but can infect humans through animal transmission[9]. While the infection
can manifest in four distinct forms, only two are relevant to human health: cystic and
alveolar. Cystic Echinococcus  infection is caused by Echinococcus granulosus  and is
characterised by the development of hydatid cysts, typically in the liver and lungs.
Alveolar  Echinococcus  infection  is  caused  by  E.  multilocularis  and  is  initially
asymptomatic, but a primary tumour-like lesion develops in the liver. This form is
fatal if untreated. The Echinococcus life cycle begins when the adult (located in the
intestine of the definitive Canidae host) releases eggs that exit the host in the faeces.
Once  ingested  by  an  intermediate  host,  i.e.  sheep,  the  eggs  hatch  and  release
oncospheres that pass through the intestinal wall and migrate into different organs.
There, the larval forms develop into cysts containing protoscolices: the form that is
ingested by the definitive host that evolves into protoscolex. Following ingestion, the
protoscolices attach to the intestinal mucosa where they develop into adults.
Recently, Koziol et al[10] proposed to identify germinal cells in E. granulosus. For this,
they treated the parasites cells with 5-Ethynyl-2´-deoxyuridine (EDU), a synthetic
nucleotide that  is  incorporated into newly synthesised DNA, to identify cells  in
proliferation. They noticed that the germinal cells were less proliferative during the
protoscolex stage but  were reactivated when ingestion by a  host  was mimicked,
highlighting  the  ability  of  these  cells  to  remain  quiescent  while  not  in  optimal
conditions.  To better  characterise this  cell  population,  they proposed to identify
potential  specific  marker  genes  using  the  whole  mount  in  situ  hybridisation
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Figure 1
Figure 1  Diagram of the three human germ layers and lineage fates. This diagram shows the different organs’ fate according to their original germ layer.
(commonly known as WMISH) technique but unfortunately were unsuccessful in this
attempt.  Notably,  germinative  cells  could  not  be  fully  eliminated  after  gamma
radiation treatment and the parasite only showed a delayed growth defect. From all
these observations, they concluded that some parasite cells are capable of self-renewal
and differentiation into proliferative competent cells.
In further work focusing on mobile genetic elements, Koziol et al[11], identified a
novel family of terminal-repeat retrotransposons in miniature (known as TRIMs) as
potential  germline  cell  markers.  Using  a  computer  modelling  approach,  they
identified putative Taeniid (Ta-)TRIMs and confirmed, by using the WMISH technic,
that their expression was strongly restricted to proliferative germinative cells. They
concluded that Ta-TRIMs could be a good marker of germinative cells in E. granulosus.
Schistosoma
Schistosoma spp are trematode worms that infect mammalian hosts. Eggs are released
into a  water  source  in  the faeces  or  urine of  the  definitive  host.  The eggs hatch,
releasing miracidia that infect aquatic snails. Once there, the parasite develops into a
sporozoite and produces cercariae. These are released into the water and penetrate the
skin of the definitive host. The parasite then sheds its characteristic forked tail to
become schistosomulae and migrates to the veins. The final venule location of the
adult  Schistosoma  is  dependant of  the species.  The females lay eggs that  migrate
through the intestines to be excreted by either urination or defecation[12].
Collins et  al[13]  in 2013 produced the first  report  on adult  somatic stem cells  in
Schistosoma mansoni. Comparing S. mansoni to already documented worms (Planarian
and Echinococcus), they investigated the possible presence of neoblast-like cells in the
parasite.  Using  EDU  labelling,  they  observed  a  proliferating  population  in  the
mesenchyme of male and female parasites. Similar genes to the ones observed in
planarian  neoblasts  were  downregulated  after  gamma  irradiation,  which  were
correlated with a potential stem cell population in the parasite. They confirmed the
self-renewal  and  differentiation  potential  of  these  cells  using  EDU/
Bromodeoxyuridine labelling studies and noted that the Sm-fgfrA  gene seemed to
promote the long-term maintenance of neoblast-like cells in S. mansoni following RNA
interference experiments. In order to better characterise these cell populations, they
investigated  gene  expression  following  gamma  radiation  and  performed  RNA
interference[14].  They  identified  135  downregulated  genes,  most  of  which  were
involved in parasite’s surface cell populations. By focusing in more detail on a specific
gene (tetraspanin, TSP-2), they observed that its expression disappeared a couple of
days after stem cell population depletion. They proposed that neoblast differentiation
was biased towards tegument cells, especially those expressing TSP-2+.
Recently, Wang et al[15] investigated the role of S. mansoni stem cells throughout the
different parasite stages, including the snail hosting period (Figure 4). Using single
RNA  sequencing  (RNA-seq)  studies,  they  identified  three  distinct  stem  cell
populations in the sporozoite stage based on the main expression of kfl nanos 2 and
fgfrA, B genes: κ cells expressing kfl+ nanos 2+,  cells expressing fgfrA, B+ and δ cells
expression both kfl+ nanos 2+ and fgfrA, B+. During the asexual stages in the snail, δ
cells were found in the embryo, as well as κ cells that were also present in extra-
embryonic tissues, while the  cells were mainly in the parasite’s outer layer and not in
WJSC https://www.wjgnet.com November 26, 2019 Volume 11 Issue 11
Matthews H et al. Stem cell and parasite interactions
906
Figure 2
Figure 2  Diagram of parasite classification. Parasite classification is based on their cellular properties. Some species examples are provided.
the daughter embryo. Notably, a fixed number of κ and δ cells seem to be kept by the
parasite while in the mammalian host where they form the source of the previously
described stem cells. Another subpopulation of stem cell derived from κ cells and
expressing eledh gene (a Schistosome-specific factor) was found in juvenal parasites and
named  ε  cells.  These  cells  can  give  rise  to  germline  or  posterior  somatic  cells
depending on the nanos-1 expression (germline if active).
Parasite and stem cell models
In addition to the study of parasite’s own stem cells, two worm species, Planaria and
Caenorhabditis elegans, although they are not or are only rarely parasitic, have served
as important models for parasite stem cell and general stem cell biology, respectively,
and will therefore be discussed further.
Planaria  are flatworms that are only rarely parasitic.  They are typically herma-
phroditic but can reproduce by fission[16]. These flatworms can be compared to the
parasitic trematode Schistosoma. One example of this is from Collins et al[17], who
studied a bioactive peptide in the planarian Schmidtea mediterranea and used this to
identify novel pro-hormones in S. mansoni.
Planarian are able to fully regenerate as they have a population of stem cells named
neoblasts[18]. Rossi et al[19] identified a group of 60 genes specific to planarian stem cells
using microarrays  and WMISH,  many of  which are  involved in  epigenetics  and
regulation of transcription. Interestingly, the planarian seems to be a good model for
human nervous system regeneration[20] due to the its high degree of conservation with
vertebrates. Moreover, Onal et al[21] found that pluripotent genes in human stem cells
were conserved in the planarian. Using fluorescence-activated cell sorting coupled
with RNA-seq studies,  they specifically identified octamer-binding transcription
factor 4, NANOG, and sex determining region Y-box 2. This later study proved that
planarian organisms are valuable models to better understand human stem cells.
C. elegans is a roundworm belonging to the nematode family. This organism is well
known by scientists as it is one of the most studied and best models for fundamental
research as summarised in Kevin Strange’s review[22]. It has been extensively used as a
parasite model[23,24]. A better understanding of C. elegans stem cell biology would allow
a better understanding of stem cell biology in general[25]. Among the many studies
involving C. elegans stem cells, we can cite the work from Seidel et al[26] who studied
stem cell quiescence following starvation, or Noormohammadi et al[27] who showed
that TRiC/CCT assembly is linked to pluripotency of human stem cells and resistance
to proteotoxic stress in C. elegans.
Parasite stem cells are evidently an interesting topic that is becoming increasingly
better studied. Although their strong regeneration capacity is beyond that of their
human  counterparts,  they  serve  to  facilitate  our  understanding  of  stem  cell
capabilities and biology in general.
INTERACTIONS BETWEEN HOST STEM CELLS AND
PARASITES
Parasites invade and occupy a number of different niches within their host species.
Consequently,  they  interact  with  stems  cells  in  a  variety  of  ways.  Many  of  the
interactions are indirect due to tissue damage caused by the parasite, which trigger
host immunity and damage repair mechanisms. Other interactions can be more direct
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Figure 3
Figure 3  Chart of the yearly number of scientific literature publications including the keywords “stem cells + parasites” over the last 50 years. This diagram
shows the numbers corresponding to scientific literature on PubMed found using the inclusive keywords “stem cells” and “parasites”.
whereby the parasite or soluble parasitic factors directly affect stem cell proliferation.
An additional layer of complexity is the ability of certain parasites to manipulate their
host by not only inducing stem cell proliferation, but also stimulating differentiation
into the parasite’s preferred cell type. Evidence of such interactions will be discussed
below.
Insect hosts
As well as infecting humans and other mammals, various insect species are subject to
parasitism. In many cases, insects serve as disease vectors transmitting the parasite
from one human to another. The parasites often go through developmental stages
within  their  host  insect  and therefore  impact  insect  fitness  and insect  stem cell
biology.
Mosquitos: The malaria parasite Plasmodium uses female Anopheles mosquitos, which
feed on mammalian blood as an intermediate host. Upon consuming a blood meal, the
parasite enters the mosquito midgut. Following transversal of the midgut epithelium,
the  parasite  undergoes  a  multiplication  phase  and  the  progeny  migrate  to  the
mosquito salivary gland. These parasites are then injected into another human during
a subsequent blood meal. During invasion and intracellular migration of the mosquito
midgut epithelium, the parasite triggers apoptosis and necrosis of invaded cells[28].
Surprisingly,  this  is  not  detrimental  to  mosquito  survival.  During  infection  of
Anopheles stephensi with Plasmodium falciparum, Baton and Ranford-Cartwright (2007)
showed that midgut regenerative cells underwent proliferation and differentiation to
replace  columnar  midgut  cells.  Moreover,  the  number  of  proliferating  and
differentiating cells correlated with the level of midgut cell destruction. This indicates
that the mosquito is able to compensate for parasitic damage through proliferative
regeneration, inadvertently permitting parasite transmission[29].
Honey bees: A similar protective mechanism to that described for the mosquito was
predicted in the honey bee, Apis mellifera. The honey bee endures enterocyte damage
during infection with the parasitic microsporidian, Nosema ceranae[30]. Despite reports
elsewhere that G1/S phase genes were upregulated during N. ceranae  infection[31],
Panek et al[32] recently showed a reduction in the replicative capacity of intestinal stem
cells during infection. Drosophila infection with the parasitic wasp Leptopilina boulardi
induces haematopoiesis through ROS-dependent induction of the Toll/NF-KB and
EGFR  pathways.  L.  boulardi  also  stimulates  the  preferential  differentiation  of
lamellocytes, increasing their proportion to nearly 50% of all haemocytes. These cells
are specifically involved in pathogen encapsulation as well as killing and implicate
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Figure 4
Figure 4  Gene expression and localisation of the different S mansoni stem cell populations in the two main hosts. This diagram explains the different
subpopulations of S. mansoni stem cells based on specific gene expression and localisation.
the existence of a “do or die” mechanism, as survival depends on the neutralisation of
wasp  eggs  before  they  hatch[33].  Evidently,  insects  have  utilised  their  stem  cell
response when necessary to permit endurance or destruction of the parasite insult.
Mammalian hosts
Helminths: Trichinella spiralis is a nematode parasite that infects many carnivorous
and omnivorous animals, including humans, and can be acquired by ingesting cysts
from contaminated/undercooked meat[34].  Infection of Balb/c mice with parasitic
worms such as T. spiralis or Heligmosomoides polygyrus (a mouse model for human
helminth infections) have been shown to induce changes in stem cell proliferation
within intestinal crypts of their hosts. T. spiralis leads to small intestine inflammation
and an initial  increase in  epithelial  stems cells  (Ki-67-positive)  and/or transient
daughter cells (day 2 post infection). This alters the architecture of the intestinal crypt
and causes an upward shift in the proliferative zone[35]. In another nematode parasite,
Trichuris muris, such alterations are considered to facilitate expulsion of the parasite
from its inter-epithelial niche[36]. However, during T. spiralis infection, the proliferative
response is not sustained. The Ki-67-positive population decreased by days 6-12 post-
infection,  while  the number of  secretory Paneth cells  increased (possibly due to
differentiation). This may be advantageous as secretory products from Paneth cells,
such  as  antimicrobial  peptides  and  proteins,  are  considered  important  for  host
protection against luminal microorganisms[35]. Conversely, adult intestinal stem cells
were  shown  to  be  repressed  in  Balb/c  mice  infected  with  H.  polygyrus.  During
infection, granuloma associated crypts exhibited loss of the adult intestinal stem cell
markers Lgr5-GFP and Olfm4, while Ly6a (which encodes stem cell antigen 1 (Sca-1)),
was  upregulated.  Nippostrongylus  brasiliensis,  a  nematode parasite  that  does  not
invade intestinal tissue, did not induce Sca-1. This suggests that upregulation of Sca-1
is a specific response to crypt injury induced by H. polygyrus. Immune cell-derived
interferon gamma (IFNγ) was critical for the granuloma associated crypt response.
Interestingly, foetal stem cell markers Gjal and Spp1 were shown to be upregulated in
the granuloma associated crypt, implicating a novel mechanism to repair intestinal
crypt disruption.
Toxoplasma:  Toxoplasma is a single-cell, protozoan parasite and is the causative agent
of toxoplasmosis. Most human infections are asymptomatic, but the disease is more
severe  in  immune  compromised  individuals  and  infants,  if  the  mother  were  to
become infected during pregnancy. Cats are the definitive host and shed the oocysts
in their faeces which can be accidentally ingested by humans and other mammals or
birds[37]. T. gondii induces apoptosis and inhibits the differentiation of neuronal stem
cells.  These  interactions  are  considered major  contributors  to  congenital  neuro-
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pathology. Various markers of apoptosis were found to be upregulated during the co-
culture of T. gondii tachyzoites and neuronal stem cells. These experiments used a
trans-well culture system, which only permits the passage of parasitic soluble factors,
not the parasite itself. Consequently, inhibition was attributed to T. gondii excreted-
secreted antigens (Tg-ESAs). The disruption of endoplasmic reticulum homeostasis
occurs in many diseases and can lead to the activation of cell death pathways. Wang et
al[38]  showed decreased apoptosis  following pre-treatment  with the endoplasmic
reticulum stress inhibitor TUDCA, implicating the involvement of the endoplasmic
reticulum stress pathway in the interaction between Tg-ESAs and neuronal stem cell
apoptosis. Tg-ESAs were also found to inhibit the differentiation of neuronal stem
cells  into  neurones  and  astrocytes.  This  was  determined  by  measuring  the
concentration of  cell  markers,  specifically  βIII-tubulin  and glial  fibrillary  acidic
protein. These decreased in a dose-dependent manner. A reduction in β-catenin and
interactivity effects between Tg-ESAs and wnt3a (an activator of the Wnt/β-catenin
pathway) implicated the involvement of the Wnt/β-catenin pathway, an important
differentiation  pathway  in  neuronal  stem  cells[39].  Further  work  implicated  the
virulence factor Rhoptry protein 18 as a partial mediator of the endoplasmic reticulum
stress-induced apoptosis and cell differentiation (Wnt/β-catenin) pathways[40].
Plasmodium: Once injected into the human host via the bite of the female Anopheles
mosquito, the parasites invade hepatocytes and multiply, forming liver schizonts[41].
These burst releasing merozoites, which invade erythrocytes, and begin the asexual
reproductive  cycle.  During  early  malarial  infection,  both  MSCs  and  HSCs  are
produced  in  the  bone  marrow  (BM)  and  subsequently  migrate  to  the  spleen.
Interestingly, adoptive transfer of P. berghei-induced MSCs conferred resistance to P.
berghei  in  naive  mice.  MSCs were  shown to  migrate  to  the  spleen,  enhance  pro-
inflammatory cytokine production (specifically interleukin 12 [IL-12]), inhibit anti-
inflammatory  cytokines  (specifically  IL-10),  and  inhibit  the  accumulation  of  T-
regulatory cells, which are induced by malaria as an immune evasion mechanism.
Adoptive transfer of MSCs in late stage infections, however, did not alter disease
progression[42]. An early haematopoiesis response is considered protective to the host,
to  counteract  erythrocyte  loss  caused by  parasite  maturation  in  red  blood cells.
Unfortunately, the response cannot sustained during the course of malaria infection
leading  to  the  common  disease-associated  pathophysiology  of  anaemia[43].  One
suggestion is  that  there  is  competition  for  the  production of  erythropoietic  and
immune cell, both derived from pluripotent stem cells[44]. Interestingly, during low
oxygen conditions the kidneys produce erythropoietin,  which in turn stimulates
erythropoiesis. During mouse infection with P. vinckei or P. chabaudi, but not P. berghei,
further erythropoiesis could be stimulated by exposing infected mice to high altitude
conditions (hypoxia) in a decompression chamber. This indicated that the infection
with P. berghei had already saturated the maximal erythropoiesis response. The initial
increase in HSCs during early infection may be due to P. berghei’s  preference for
invasion of reticulocytes. However, cellularity (total number of nucleated cells) and
subsequently  erythropoietic  capacity  in  the  BM decreased  during  the  course  of
malaria infection. Despite enlargement and an increase in cellularity, the spleen does
not compensate to meet the erythropoietic and hemopoietic needs of the host, which
leads to anaemia. Although there are reports that pluripotent stems cells remain in G0
and are therefore protected, the lethality and severity of anaemia during malaria
infection may be determined by irreversible damage to the self-renewal capacity of
hematopoietic stems cells, as observed with chronic leishmania infection[45].
Leishmania: Leishmania spp have a broad spectrum of interactions with various host
stem cell lineages. Although macrophages are their primary host, they have been
shown to be capable of infecting a variety of cells including different types of stems
cells both in vitro and in vivo[46-49]. Allahverdiyev et al[47] showed in vitro invasion of
adipose tissue-derived mesenchymal stem cells by L. donovani, L. major, L. tropica, and
L. infantum parasites, raising potential concerns about stem cell transplantations and
parasite transmission, which is discussed in more detail later. BM-derived MSCs (BM-
MSCs) were also shown to be vulnerable to L. infantum and L. donovani invasion in an
in vivo mouse model. This was confirmed by confocal microscopy and co-staining
with antibodies for parasites and MSCs (CD271+/Sca1+) isolated from both the BM
and  spleen  of  infected  mice.  Interestingly,  the  authors  not  only  visualised  this
invasion events ex vivo, but determined the viability of the amastigotes identified in
BM-MSC CD27+CD45 cells by inoculating the infected cells into an axenic in vitro
culture system. Then promastigote forms were detected. Since MSCs have potent
drug efflux pumps, the proposed purpose of this interaction is the potential avoidance
of drug-induced death. This is considered particularly important for latent infections
that occur despite treatment. Such stem cells niches could also serve as a “hide-out”
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for parasites during asymptomatic infections.
As well  as  the modulation of  host  stem cell  proliferation,  following the direct
invasion of  stem cells,  tissues  infected with  Leishmania  parasites  have also  been
reported to display alterations in host cytokine/chemokine expression and stem cell
proliferation. Dameshghi et al[50] in 2016 isolated macrophages and adipose-derived
MSCs from mice that were either sensitive or resistant to Leishmania. Isolated cells
were placed, in various combinations, in a trans-well system. After 72 h of co-culture
the MSC chamber was removed and the macrophage supernatant was replaced before
challenge with L. major promastigotes. These macrophages, now considered MSC-
educated, showed a reduction in phagocytosis, nitric oxide, IL-10, tumour necrosis
factor alpha production and an induction in inflammatory cytokines in response to L.
major  infection.  This response was independent of prior sensitivity to Leishmania
(although  the  magnitude  of  the  response  did  vary  between  treatment-group
combinations).  This  implicates  MSCs  as  the  sensors  and  switchers  of  immune
modulation and supports the potential of stem cells as a treatment for leishmaniasis.
Local  alterations  in  hematopoietic  activity  have  also  been  reported  in  tissues
harbouring  L.  donovani  amastigotes  in  vivo[51].  Infection  leads  to  an  increase  in
progenitor  cell  frequency in  the blood,  and a  correlation was observed between
hematopoietic activity and parasite proliferation in the spleen and BM. Tissue-specific
regulation of cytokine and chemokine expression was also observed, with an increase
in those associated with monocyte and granulocyte maturation from multipotential
precursors. Leishmania-infected stromal cells also display an enhanced capacity in
vitro,  through  cytokine  regulation,  to  support  the  differentiation  of  regulatory
dendritic cells from hematopoietic progenitor cells[52]. The recombinant heat shock
protein 70, from a related kinetoplastid parasite Trypanosoma cruzi, was also shown to
have an immune-stimulatory effect on the maturation of dendritic cells from BM
precursors. Remarkably, dendritic cell maturation occurred in the presence of the
recombinant protein alone, fused to the KMP11 antigen as well as a 242-amino acid
protein fragment[53].  This again could have implications for therapy. As the main
source of immune cells, it is not surprising that BM-hematopoietic stem/progenitor
cells  are  activated during Leishmania  infection.  This  is  consistent  with the stress
response to other acute infections[54]. However, L. donovani was shown to be capable of
host manipulation by skewing HSC expansion to the differentiation of non-classical
myeloid progenitor cells. Interestingly, cells produced in this manner were not only
the preferred target  of  the parasite  but  were also more permissive to Leishmania
infection, providing evidence of parasite manipulation[54]. Acute infections can give
rise  to  such expansion that  cannot  be  sustained during chronic  infection.  Using
adoptive transfer of IFNγ sufficient CD4+ T cells into immune-deficient mice, Pinto et
al[55]  in 2017 showed that chronic stimulation of HSC expansion, by this pathway,
leads to hematopoietic exhaustion. In this instance, the reservoir of long-term HSCs
irreversibly  loses  quiescence  and  enters  into  an  active  cell  cycle,  where  they
eventually lose their self-renewal capacity. During chronic infections, an effective
anti-parasitic response is therefore at the expense of the reservoir of quiescent LT-HSC
hematopoietic  fitness.  The  importance  of  this  trade-off  for  sufferers  of  life-long
chronic infections is yet to be determined.
Evidently, parasites can develop a range of complex interactions with their host’s
stem cells by modulating their expression and fate. Although the growing body of
research into this area in recent years (Figure 3) has meant that we know more now
than ever before, the field remains in its infancy. Most of the aforementioned studies
were conducted in insect or mouse models, as obvious technical and ethical issues
limit human in vivo investigations. Due to the complexity of parasite life cycles, often
having distinct development stages in multiple host tissues,  studies into general
parasite  biology during human infection are  also  limited by the  in  vitro  culture
systems  we  have  available.  However,  as  our  in  vitro  capabilities  for  stem  cells
production have expended parasitologist can utilise stems cells in order to recreate
and study parasite development within a variety of host tissues that were previously
inaccessible. Examples of such studies are detailed in Table 1. The availability of these
valuable  model  systems will  not  only permit  a  better  understanding of  parasite
biology but may open up new avenues for parasite treatment.
STEM CELL AND PARASITE THERAPIES
Stem cell therapies have become increasingly more applied as potential cures for
important diseases such as liver injuries, muscle degeneration or anaemia[56]. These
therapies aim to replace dysfunctional cells or tissues with the transplantation of
newly generated and functional stem cells. In addition to these applications, a new
WJSC https://www.wjgnet.com November 26, 2019 Volume 11 Issue 11
Matthews H et al. Stem cell and parasite interactions
911
Table 1  Table of stem cell classes used to model parasite infections
Stem cell type Parasite Details Futurepurpose/possibilities Ref.
Hematopoietic Plasmodium vivax Cluster of differentiation 34+
derived reticulocytes
Growing Plasmodium species
that have a reticulocytes
preference
Grosgogeat et al[100]
Leishmania infantum BM HSCs-derived white cells
were capable of
phagocytosing and
supporting promastigote
development
Better understanding of
promastigote development
within macrophages
Carvalho-Gontijo et al[101]
Neuronal Toxoplasma gondii Fibroblast-derived and
CD34+-derived human
neuronal-like cells were
capable of supporting T.
gondii tachyzoite
development
Better understanding of
parasite behaviour and
development within human
brain cells
Passeri et al[102], Tanaka et
al[103]
Liver cells Plasmodium falciparum, vivax,
yoelii, and berghei
Human iPSC-derived
hepatocyte-like cells,
expressing important
Plasmodium entry receptors
CD81 and the SRB1, were
permissive to the
development many
Plasmodium species
Better understanding of liver
stage infection. Particularly
for species such as
Plasmodium vivax that can
remain dormant in the liver
and recrudesce many years
later
Teranishi et al[104]
BM: Bone marrow; CD: Cluster of differentiation; HSCs: Hematopoietic stem cells; iPSCs: Induced pluripotent stem cells; SRB1: Scavenger receptor class B
type 1.
field of use for stem cell therapy has recently emerged: Parasitic treatment. The aim of
these treatments is not to directly target the parasite itself but to help the patient fight
and recover post infection, as we will discuss further in this section.
Trypanosoma
The first parasite infection that we will cover is the kinetoplastid parasite T. cruzi. This
parasite is responsible for Chagas disease, that affects up to 7 million people, and
predominantly occurs in Latin America[57]. The disease is curable if treated during
early stage of infection, however treatment efficacy decreases with time. There are
two distinct infection stages: Acute and chronic. The former stage can last up to 2 wk
and,  though  the  patient  may  have  a  high  parasitaemia,  the  symptoms  remain
relatively mild and non-specific[58]. The latter stage can be subdivided into determi-
nate and indeterminate phases. The determinate phase is marked by an equilibrium
stage where host and parasites co-exist  with no damage. Following an unknown
mechanism, up to 30% of the patients will switch to the indeterminate phase. During
this stage, Chagas disease-associated severe complications such as gastrointestinal or
chronic  heart  diseases  occur.  Chagas heart  disease remains the most  severe and
prevalent complication (45% of the chronic patients), which explains why it has been
more  extensively  described.  It  is  characterised  by  an  extensive  fibrosis  of  the
myocardium that can evolve into chronic heart failure[59]. The treatment for Chagas
heart  disease  cases  are  symptom  dependent  but  can  eventually  lead  to  a  heart
transplant. This has further associated consequences and due to immunosuppression
could lead to the reactivation of the parasitic infection[60]. It is thus very important to
find an alternative method to repair cardiac tissue affected by the parasite. Soares et
al[61]  in 2004 were the first to use MSCs to treat heart failure following a parasitic
infection. They transplanted BM of a healthy mouse into a mouse model of Chagas
heart disease and observed a reduction in inflammation and fibrotic areas by 80% and
90% respectively. Interestingly, BMC treatment was shown to affect the myocardium
transcriptome  by  decreasing  the  expression  of  upregulated  genes  involved  in
inflammation and fibrotic events in T. cruzi-infected mice[62]. One striking example is
the strong downregulation of Galectin-3. Galectin-3 is a protein that is expressed by
macrophages and correlates with inflammation in the mouse model of Chagas heart
disease via its involvement in the induction of collagen production, proliferation of
cardiac fibroblast and T-cell apoptosis suppression. This work implicates Galectin-3 as
a potential therapeutic target and highlights the possible use of BMC injection as anti-
inflammatory and anti-fibrotic treatment of Chagas’s heart disease.
Following the initial success with mouse-models (reviewed by Carvalho et al[63]) the
next step was to evaluate whether such results could be achieved during human
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infection. The first  clinal trial  took place on a 52-year-old man suffering of heart
failure due to T. cruzi infection[64]. Purified mononuclear cells, isolated from healthy
BM,  were  injected  into  the  patient  and  an  improved  ventricular  function  was
observed 30 d post-transplantation. This first success lead to additional studies which
further  expanded to a  multi-centre  randomised clinical  trial.  Over a  total  of  183
patients were treated with BM mononuclear cells in conjunction with granulocyte-
colony stimulating factor. Unfortunately, no improvement in cardiac function was
observed[65]. Although the results with the BM-derived mononuclear cells were not as
good as expected, the use of a different type of stem cells,  MSCs, did yield some
interesting results and showed immunomodulatory properties as well as the potential
for use in chronic chagasic cardiomyopathies[66].  Notably, only a small fraction of
injected MSCs actually migrated to the heart in a Chagas mouse model. Indeed, nearly
70% could be found in liver, lungs, and spleen. Nevertheless, a reduction of the right
ventricular  dilatation was observed after  MSC transplantation in Chagas mouse
models. A further study showed that MSC treatment could influence gene expression
and more especially the extracellular matrix protein laminin γ1 that was upregulated
in infected mice compared to the MSCs treated ones[67]. Interestingly, two antagonist
factors  (the  pro-inflammatory  INFγ and the  anti-inflammatory  IL-10)  that  were
upregulated in infected mice are down-regulated after  MSC treatment.  The pro-
inflammatory stromal cell-derived factor-1 gene was also upregulated after MSC
treatment, which could be correlated to the attraction of additional stem cells to the
damaged area. More recently, Larocca et al[68] did not observe any cardiac function
improvements  following  adipose-derived  MSCs  but  a  decrease  in  fibrosis  and
inflammatory cells. Evidently, there has been some difficulty in defining effective
stem cell therapeutic targets, and further translating these from Chagas heart disease
mouse  models  to  the  human disease  system,  but  the  value  of  such  a  treatment
warrants further research into this area.
Leishmania spp
Leishmaniasis is a parasitic infection that can take different forms dependent on the
parasitic strain. Three distinct forms affect different targets: the cutaneous form (that
can be caused by almost any leishmania spp)  affects the skin with the presence of
lesions, the mucocutaneous form (caused by L. Donovani and L. infantum) leads to a
partial or full destruction of mucosal membranes around the mouth, nose or throat
while the visceral form affects the liver, BM, and spleen[69]. Leishmaniasis symptoms
can also be due to an alteration of the host immune response. Knowing that MSCs can
modulate the immune response[70], it seems reasonable to use these cells as therapy
against cutaneous leishmania as Pereira et al[71] investigated. Unfortunately, they did
not observe any protective effect, post-MSC injection, in a mouse model of cutaneous
infection and even reported an increase in parasitic burden dependent on the route of
MSC administration. This increase was correlated to an increase of IL-10 producing
CD4+ and CD8+ T cells in the spleen. Of note, Il-10 is an anti-inflammatory cytokine
that can limit the ability of macrophages to kill intracellular organisms and the lack of
T-cell-derived  IL-10  enhances  protection  from  L.  major  infection  in  mouse  as
previously described[72]. Besides cutaneous leishmaniasis, stem cell therapies could be
applied to other Leishmania strains such as the visceral and mucocutaneous forms of
the disease. Studying L. major (responsible for the visceral form), Dameshghi et al[50]
obtained promising immunomodulatory results from a cell-based assay, nevertheless
the results still have to be translated to an in vivo system.
Schistosoma
Schistosomiasis is caused by a parasitic trematode. These worms remain in the host’s
blood vessels where the female lays the eggs that are the primary cause of pathology
during chronic disease[73]. Proteolytic enzymes released by the eggs trigger a T-helper
type 2 response that can lead to the fibrosis of affected tissues[74]. There are two main
types of schistosomiasis infection: Urogenital schistosomiasis caused by S. haemato-
bium and hepatic schistosomiasis caused by S. mansoni, S. intercalatum, S. japonicum,
and S. mekongi[75]. The urogenital schistosomiasis can lead to fibrosis of the bladder
and lower ureters and can even evolve to kidney failure. The hepatic schistosomiasis
shows two distinct  forms:  Fibrotic  hepatic  disease  and early  inflammatory.  The
fibrotic hepatic disease (Symmer’s pipestem fibrosis) is caused by the deposition of
collagen in the periportal spaces, leading to the tissue’s hypoxia. Studies have already
been conducted to investigate the potential of MSCs to cure these symptoms and a
decrease of liver fibrosis has been observed in treated mouse models of S. mansoni[76].
Moreover,  El-Shennawy et  al[77]  recently showed that a treatment with BM-MSCs
significantly decreased the granulomas size and the expression of  alpha-smooth
muscle actin (a fibrosis factor) in hepatic stellate cells. The anti-fibrotic effect of the
MSCs was not limited to these features and it included the inhibition of collagen
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deposition, a downregulation of transforming growth factor β1 and an upregulation
of matrix metalloprotease 9, a matrix metalloprotease that leads to hepatic stellate
cells apoptosis. As hepatic stellate cells are involved in the hepatic fibrosis process
during liver injury[78], early injection of MSCs to trigger their apoptosis may lead to a
more efficient cure. MSCs have also been used to treat S. japonicum mouse models
using single injections or in combination with praziquantel (current drug treatment
against schistosomiasis) and a recovery of the spleen and liver was observed due to
the inhibition of the collagen deposition[79]. Another stem cell source has been tested
by Elkhafif et al[80] in 2011 who used CD133+ human umbilical cord blood stem cells to
trigger the production of new blood vessels in order to promote vascularisation. This
neo-vascularisation created a permissive environment allowing better survival of
damaged cells.
Plasmodium
The Plasmodium parasite,  the causative agent of malaria,  is  an important public
health  threat.  Symptoms  of  the  infection  are  initially  non-specific  and  include
headache, fever and fatigue[81]. How the infection progresses will then be defined as
uncomplicated or severe (complicated) malaria. The severe form can be fatal with
symptoms including consciousness, convulsions, bleeding, anaemia, renal impair-
ment and pulmonary oedema[82]. The erythrocyte is one niche exploited by parasite in
the human host and during a 48 or 72 h erythrocytic cycle (dependent on the species)
the parasite continuously occupies, destroys and invades yet more red blood cells,
thus having a huge impact on blood cell homeostasis. Knowing this feature, the use of
HSC could be an interesting therapeutic approach. Indeed, Belyaev et al[83] in 2010
identified, in the BM of P. chabaudi  infected mice, a new subset of haematopoietic
progenitors triggered by IFNγ signal. The injection of these healthy atypical HSC
progenitors within infected mice showed a greater clearance of infected erythrocytes
leading to a decrease in infection-associated anaemia. MSCs isolated from the spleen
of P. berghei infected mice, could be transplanted to naïve mice prior their exposition
to P.  berghei[42].  Interestingly,  these MSCs produced protective cytokines such as
tumour necrosis factor alpha and IL-1β that decreased the production of haemozoin
(product  from the erythrocyte  haem degradation).  This  helps  to  counteract  host
evasion mechanisms used by the parasite as hemozoin inhibits macrophages and
decreases the number of Treg cells in the spleen[84]. These cells can be used to treat
cerebral malaria, a severe complication of P. falciparum infection, characterised by
neurological symptoms including coma, convulsion, drowsiness and confusion and
can  affect  spleen,  kidneys  and  lungs[85].  Treatment  of  BM-MSCs  improved  the
clearance of parasitised erythrocytes, increased the regeneration of hepatocytes and
Kupffer cells (specific phagocytic cells) and increased the number of astrocytes and
oligodendrocytes in the brain. In parallel, lung inflammation was reduced, by limiting
collagen  deposition,  and  the  number  of  neutrophils,  and  amount  of  malaria
pigmentation was decreased while the mesangial  architecture of  the kidney was
restored[86]. Despite all these improvements, no reduction of the brain damage was
observed.
Stem cell therapies have the potential to significantly alter the way in which we
treat  parasitic  infections  (Figure  5).  The  transplantation  of  stem cells  to  aid  the
recovery of  damaged organs remains  a  really  interesting addition to  traditional
parasitic cure methods. However, these methods and techniques are still  in their
infancy, and the affordability of stem cell-based therapies will be a significant factor in
their uptake, particularly in developing countries where these neglected tropical
diseases predominate[87].
Parasitic infections and transplantation
The future availability of stem cell therapies were predicted to be revolutionary for
the cure of multiple disease as emphasised by the recent increase in interest in this
research area and the number (7150 with the term “stem cells”)  of  clinical  trials
registered with clinicaltrials.gov. Nevertheless, only HSCs have been so far approved
by United States Food and Drug Administration to serve as cure therapy[88]. They are
mainly used, through BM transplantation, to cure blood disorders such as leukaemia
or myeloma. Prior to any transplantation, donations are screened for any potential
infection. Some screens such as HIV 1+2, hepatitis C, hepatitis B, syphilis, human T-
lymphotropic  virus  1+2  are  mandatory  in  United  Kingdom [ 8 9 ] .  However
cytomegalovirus,  malaria,  Trypanosoma cruzi  and West  Nile virus remain simply
additional.  These additional screens are only performed if  a donor risk has been
identified.  Multiple  parasitic  infections  have been identified in  recipient’s  post-
transplantation (as discussed below). However, the immunosuppressive medication
following  an  allogenic  transplantation  makes  the  patient  more  sensitive  to
opportunistic parasitic infections and must be considered as a potential source/ route
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Figure 5
Figure 5  Parasitic infections and stem cell therapies targeting different organs. This diagram shows the
different stem cell therapies used for different parasite infections and the targeted organs.
of infection without the availability of donor pre-screens.
Though Leishmaniasis does not appear on the list of infectious pathogens screened
prior to transplantation, its ability to survive within an intracellular environment by
creating a suitable niche for replication[90]  remains a threat.  Indeed, although the
parasite primarily invades phagocytic cells, i.e. macrophages, the amastigote form has
been  found  in  fibroblasts[48],  hepatocytes[49]  and  amniotic  epithelial  cells[91].  The
potential  of  Leishmania  to  survive  in  MSC  has  been  recently  investigated  by
Allahverdiyev et al[47] who were able to observe an in vitro infection of adipose-derived
MSCs by L. tropica, L. donovani, L. major and L. infantum.
Of note, several cases of leishmania infections post MSC transplantations have been
documented[92,93] though the presence of the parasite in the transplant was not proved.
Several hypotheses could be raised, i.e. an infectious sand fly bite post transplantation,
a latent infection in the patient or a re-activation of the opportunist parasite due to the
immunosuppressive treatment. The Plasmodium parasite has also been described in
the BM of an infected individual[94] and has been reported to be capable of invading
HSC progenitors[95]. Moreover, the parasite, once in the human host, remains in the
liver for 7 to 10 d and sometimes for a longer period as the hypnozoite form. For these
reasons, reports of malaria infection following transplantation are not surprising.
Indeed, Martín-Dávila et al[96] recently reported patients infected by P. malariae and P.
ovale after liver and kidney transplantations. Parasite transmission can also occur after
BM transplantation  as  described in  a  recent  case  even  when the  donor  was  not
classified at risk[97].
Toxoplasma is a parasite that does not appear on the list of pathogen screens prior to
transplantation as they are unlikely to be found in stem cells. Nevertheless, several
cases  of  toxoplasmosis  infected  patients  post-HSC  transplantation  have  been
described[98] mostly as an opportunistic infection following the immunosuppression
treatment  post-transplantation.  Another  parasite  taking advantage  of  the  lower
immune defence post stem cell injection is cryptosporidium, which has also been
identified in patients post transplantation[99].
It  is  thus  necessary  to  consider  parasites  during  the  screening  process  pre-
transplantation and not only based on donor recent travel history to endemic areas.
The  follow up post-transplantation  monitoring  should  also  not  be  neglected  as
opportunistic infections represent an important threat.
CONCLUSION
As can be seen from this review, the two seemingly distinct fields of stem cell research
and parasitology are in fact closely entwined. Not only do multicellular parasites have
stem cells of their own, but certain parasites exploit stem cells to create niches either
within their host stem cells, or by modulating host stem cell activity to create a more
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habitable environment. The use of stem cells as therapies to treat either the parasitic
diseases or, more commonly, the sequalae associated with the infection, is becoming
increasingly  more  studied.  The  presented  literature  allows  us  to  highlight  the
importance  of  considering  stem cells  as  important  targets  for  parasites  and not
underestimate this relationship from a clinical point of view.
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